Corporate sponsorship
The sponsoring of IgG4ward! is a partnership in innovation and empathy.
Corporate sponsorship
The sponsoring of IgG4ward! is a partnership in innovation and empathy.
Why consider sponsorship?
IgG4-RD is a rare disease that is only now coming into light. The clinical progress over the past 15 years has been astounding, but there is much more to uncover within diagnosis, treatment, management, and ultimately a cure. Our sponsors not only support our mission, but lead the way in giving IgG4-RD patients a better life.
Amgen
Our partnership with Amgen led to the first international clinical trial ever performed in IgG4-RD. The trial, named MITIGATE, was a landmark moment for IgG4ward!, Amgen, and patients living with this rare disease. The MITIGATE trial enrolled patients from 22 different countries to participate in a B cell depletion medicine called inebilizumab. The completion of this stage 3 clinical trial revealed that inebilizumab reduced the risk of IgG4-RD flare by 87% compared to the standard treatment arm. While much work remains ahead, IgG4-RD patients now have access to an effective FDA-approved drug.
Zenas BioPharma
A valued partner in advancing the IgG4ward! mission, Zenas supports the Foundation through contributions that help sustain advocacy efforts and patient-centered initiatives, including international and U.S. based in-person patient events (The JAMs). This support helps foster community engagement and provides opportunities for patients to connect and learn.
Tellus BioVentures
An early partner in advancing the IgG4ward! mission, Tellus BioVentures provided critical foundational support to help establish the IgG4ward! Foundation. This early investment enabled the development of programs and initiatives serving the IgG4-RD community.
Acepodia
A valued partner in advancing the IgG4ward! mission, Acepodia supports the Foundation through funding for patient-centered initiatives, including the History of IgG4-RD film, CanJAM, PeachJAM, and the International Symposium on IgG4-RD. This support expands educational opportunities and strengthens connections across the IgG4-RD community.
Sanofi
A valued partner in advancing the IgG4ward! mission, Sanofi supports the Foundation through funding for educational and community initiatives, including the History of IgG4-RD film, EuroJAM, and the International Symposium on IgG4-RD. These efforts support awareness and education and bring the global IgG4-RD community together.
Amgen
A valued partner in advancing the IgG4ward! mission, Amgen provided critical early funding and continues to support the Foundation through annual contributions and funding for patient-centered initiatives, including international and U.S.- based in-person and virtual patient events (The JAMs). This support helps strengthen community connections and expand education, resources, and awareness.
The Moulder Family Foundation
An early and enduring partner in advancing the IgG4ward! mission, The Moulder Family Foundation provided critical initial funding and continues to support the Foundation through generous annual contributions. Their ongoing support sustains core programs and helps expand the Foundation’s reach within the IgG4-RD community.